skinMicromin is a form of Transdermal Micronutrition (TDM) that is a treatment of certain effects of iron-deficiency anemia. Micromin has other potential applications as well, including in the area of environmental medicine where its ion-substitution effect can help ward off many kinds of toxic substances.

Micromin exploits a capability that human beings have inherited from distant ancestors. Its action suggests that in certain circumstances human beings can exhibit behavior reminiscent of medusa and polyp stages; and that the transition between the two can convey certain unusual benefits, especially in the area of gynecology and obstetrics. Micromin’s abilities to bypass the liver and to provide a steady supply of micronutrients differentiate it from gastrointestinal feeding and may explain some of its effects. There are some indications that Micromin’s mechanism of action overlaps with—and thus may elucidate—the mechanism of action of Traditional Chinese Medicine moxa therapy (moxibustion). In turn, this may mean that Micromin will prove effective in the various and at times remarkable indications for which moxa has traditionally been employed. Continue reading »

Tags: , , , ,

painThe finding that NSAIDs can cause heart attacks and strokes in certain patients  has disrupted the lives of millions of arthritis patients as well as throwing a scare into the pharmaceutical industry.

But it needs to be put in perspective. There is no better place to start than with the famous dictum of the Swiss Renaissance physician Paracelsus: “All things are poison, and nothing is without poison. It is the dose alone that makes a thing not a poison.” In the case of the painkillers, it is likely that lower doses and limits on the duration of therapy would avoid most problems. Quite possibly, some of the people who suffered heart damage belonged to high risk categories for whom most or all prescription painkillers would be dangerous. In fact, NSAIDs and other pain relief drugs have shown themselves to be very effective and safe for certain groups of patients in modest doses for limited periods of time, so it is unreasonable to withdraw them from the market. Of course, they should compete there on the basis of their merits compared to other drugs. Continue reading »

Tags: , , , , ,
Copyright © Scientia Press, 2020
© 2009 Designed by Sayontan Sinha Wordpress Themes